ReP USP - Resultado da busca

Artigo de periodico
Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception (2025)
Giarolla, Jeanine ; Holdaway, Kelsey A ; Nazari, Maryam; Aiad, Laila; Sarkar, Bidisha; Georg, Gunda I
Fonte: Future Medicinal Chemistry. Unidade: FCF
Assuntos: LIGANTES, NEOPLASIAS, ENSAIO CLÍNICO, LIGANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIAROLLA, Jeanine et al. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry, v. 17, n. 5, p. 607–627, 2025Tradução . . Disponível em: https://dx.doi.org/10.1080/17568919.2025.2463868. Acesso em: 08 out. 2025.
APA
Giarolla, J., Holdaway, K. A., Nazari, M., Aiad, L., Sarkar, B., & Georg, G. I. (2025). Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry, 17( 5), 607–627. doi:10.1080/17568919.2025.2463868
NLM
Giarolla J, Holdaway KA, Nazari M, Aiad L, Sarkar B, Georg GI. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception [Internet]. Future Medicinal Chemistry. 2025 ; 17( 5): 607–627.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1080/17568919.2025.2463868
Vancouver
Giarolla J, Holdaway KA, Nazari M, Aiad L, Sarkar B, Georg GI. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception [Internet]. Future Medicinal Chemistry. 2025 ; 17( 5): 607–627.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1080/17568919.2025.2463868
Artigo de periodico
Innovative approaches to an eco-friendly cosmetic industry: a review of sustainable ingredients (2024)
Sasounian, Rafaela; Martinez, Renata Miliani ; Lopes, André Moreni ; Giarolla, Jeanine ; Rosado, Catarina ; Magalhães, Wagner Vidal ; Velasco, Maria Valéria Robles ; Baby, André Rolim
Fonte: Clean Technologies. Unidades: EEL, FCF
Assuntos: COSMÉTICOS, QUÍMICA VERDE, MATERIAIS RECICLÁVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SASOUNIAN, Rafaela et al. Innovative approaches to an eco-friendly cosmetic industry: a review of sustainable ingredients. Clean Technologies, v. 6, n. 1, p. 176-198, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cleantechnol6010011. Acesso em: 08 out. 2025.
APA
Sasounian, R., Martinez, R. M., Lopes, A. M., Giarolla, J., Rosado, C., Magalhães, W. V., et al. (2024). Innovative approaches to an eco-friendly cosmetic industry: a review of sustainable ingredients. Clean Technologies, 6( 1), 176-198. doi:10.3390/cleantechnol6010011
NLM
Sasounian R, Martinez RM, Lopes AM, Giarolla J, Rosado C, Magalhães WV, Velasco MVR, Baby AR. Innovative approaches to an eco-friendly cosmetic industry: a review of sustainable ingredients [Internet]. Clean Technologies. 2024 ; 6( 1): 176-198.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3390/cleantechnol6010011
Vancouver
Sasounian R, Martinez RM, Lopes AM, Giarolla J, Rosado C, Magalhães WV, Velasco MVR, Baby AR. Innovative approaches to an eco-friendly cosmetic industry: a review of sustainable ingredients [Internet]. Clean Technologies. 2024 ; 6( 1): 176-198.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3390/cleantechnol6010011
Artigo de periodico
Canis Lupus familiaris and diclofenac: understanding the potential risks of this association (2024)
Menezes, Bruna Lohmann; Giarolla, Jeanine ; Santos, Yasmin da Silva ; Petri, Giuliana; Epiphanio, Sabrina
Fonte: Frontiers in Veterinary Science. Unidade: FCF
Assuntos: TOXICIDADE EM ANIMAL, ANTI-INFLAMATÓRIOS NÃO ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEZES, Bruna Lohmann et al. Canis Lupus familiaris and diclofenac: understanding the potential risks of this association. Frontiers in Veterinary Science, v. 11, p. 1-6, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fvets.2024.1507390. Acesso em: 08 out. 2025.
APA
Menezes, B. L., Giarolla, J., Santos, Y. da S., Petri, G., & Epiphanio, S. (2024). Canis Lupus familiaris and diclofenac: understanding the potential risks of this association. Frontiers in Veterinary Science, 11, 1-6. doi:10.3389/fvets.2024.1507390
NLM
Menezes BL, Giarolla J, Santos Y da S, Petri G, Epiphanio S. Canis Lupus familiaris and diclofenac: understanding the potential risks of this association [Internet]. Frontiers in Veterinary Science. 2024 ; 11 1-6.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3389/fvets.2024.1507390
Vancouver
Menezes BL, Giarolla J, Santos Y da S, Petri G, Epiphanio S. Canis Lupus familiaris and diclofenac: understanding the potential risks of this association [Internet]. Frontiers in Veterinary Science. 2024 ; 11 1-6.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3389/fvets.2024.1507390
Artigo de periodico
Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents (2023)
Vassiliades, Sandra Valeria ; Borges, Lara Gimenez; Giarolla, Jeanine ; Parise Filho, Roberto
Fonte: Mini-Reviews in Medicinal Chemistry. Unidade: FCF
Assuntos: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 08 out. 2025.
APA
Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
NLM
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Vancouver
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Artigo de periodico
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies (2023)
Vaz, Elisa Souza; Vassiliades, Sandra Valeria ; Giarolla, Jeanine ; Polli, Michelle Carneiro; Parise Filho, Roberto
Fonte: European Journal of Clinical Pharmacology. Unidade: FCF
Assuntos: PANDEMIAS, COVID-19, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAZ, Elisa Souza et al. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European Journal of Clinical Pharmacology, v. 79, p. 723–751, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00228-023-03486-4. Acesso em: 08 out. 2025.
APA
Vaz, E. S., Vassiliades, S. V., Giarolla, J., Polli, M. C., & Parise Filho, R. (2023). Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European Journal of Clinical Pharmacology, 79, 723–751. doi:10.1007/s00228-023-03486-4
NLM
Vaz ES, Vassiliades SV, Giarolla J, Polli MC, Parise Filho R. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies [Internet]. European Journal of Clinical Pharmacology. 2023 ; 79 723–751.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s00228-023-03486-4
Vancouver
Vaz ES, Vassiliades SV, Giarolla J, Polli MC, Parise Filho R. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies [Internet]. European Journal of Clinical Pharmacology. 2023 ; 79 723–751.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s00228-023-03486-4
Artigo de periodico
Resveratrol and curcumin for Chagas disease treatment—a systematic review (2022)
Imperador, Carlos Henrique Lima ; Scarim, Cauê Benito ; Bosquesi, Priscila Longhin ; Lopes, Juliana Romano ; Cardinalli Neto, Augusto; Giarolla, Jeanine ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Chin, Chung Man
Fonte: Pharmaceuticals. Unidade: FCF
Assuntos: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IMPERADOR, Carlos Henrique Lima et al. Resveratrol and curcumin for Chagas disease treatment—a systematic review. Pharmaceuticals, v. 15, p. 1-19 art. 609, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15050609. Acesso em: 08 out. 2025.
APA
Imperador, C. H. L., Scarim, C. B., Bosquesi, P. L., Lopes, J. R., Cardinalli Neto, A., Giarolla, J., et al. (2022). Resveratrol and curcumin for Chagas disease treatment—a systematic review. Pharmaceuticals, 15, 1-19 art. 609. doi:10.3390/ph15050609
NLM
Imperador CHL, Scarim CB, Bosquesi PL, Lopes JR, Cardinalli Neto A, Giarolla J, Ferreira EI, Santos JL dos, Chin CM. Resveratrol and curcumin for Chagas disease treatment—a systematic review [Internet]. Pharmaceuticals. 2022 ; 15 1-19 art. 609.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ph15050609
Vancouver
Imperador CHL, Scarim CB, Bosquesi PL, Lopes JR, Cardinalli Neto A, Giarolla J, Ferreira EI, Santos JL dos, Chin CM. Resveratrol and curcumin for Chagas disease treatment—a systematic review [Internet]. Pharmaceuticals. 2022 ; 15 1-19 art. 609.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ph15050609
Artigo de periodico
Vaccinium myrtillus L. extract associated with octocrylene, bisoctrizole, and titanium dioxide: in vitro and in vivo tests to evaluate safety and efficacy (2022)
Ruscinc, Nadia; Jacome, Ana Lucia Morocho ; Martinez, Renata Miliani ; Magalhães, Wagner Vidal ; Escudeiro, Cassiano Carlos; Giarolla, Jeanine ; Rosado, Catarina ; Velasco, Maria Valéria Robles ; Baby, André Rolim
Fonte: Journal of Cosmetic Dermatololy. Unidade: FCF
Assuntos: RADIAÇÃO ULTRAVIOLETA, FILTRO SOLAR, TITÂNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSCINC, Nadia et al. Vaccinium myrtillus L. extract associated with octocrylene, bisoctrizole, and titanium dioxide: in vitro and in vivo tests to evaluate safety and efficacy. Journal of Cosmetic Dermatololy, v. 21, n. 10, p. 4765-4774, 2022Tradução . . Disponível em: https://doi.org/10.1111/jocd.14779. Acesso em: 08 out. 2025.
APA
Ruscinc, N., Jacome, A. L. M., Martinez, R. M., Magalhães, W. V., Escudeiro, C. C., Giarolla, J., et al. (2022). Vaccinium myrtillus L. extract associated with octocrylene, bisoctrizole, and titanium dioxide: in vitro and in vivo tests to evaluate safety and efficacy. Journal of Cosmetic Dermatololy, 21( 10), 4765-4774. doi:10.1111/jocd.14779
NLM
Ruscinc N, Jacome ALM, Martinez RM, Magalhães WV, Escudeiro CC, Giarolla J, Rosado C, Velasco MVR, Baby AR. Vaccinium myrtillus L. extract associated with octocrylene, bisoctrizole, and titanium dioxide: in vitro and in vivo tests to evaluate safety and efficacy [Internet]. Journal of Cosmetic Dermatololy. 2022 ; 21( 10): 4765-4774.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/jocd.14779
Vancouver
Ruscinc N, Jacome ALM, Martinez RM, Magalhães WV, Escudeiro CC, Giarolla J, Rosado C, Velasco MVR, Baby AR. Vaccinium myrtillus L. extract associated with octocrylene, bisoctrizole, and titanium dioxide: in vitro and in vivo tests to evaluate safety and efficacy [Internet]. Journal of Cosmetic Dermatololy. 2022 ; 21( 10): 4765-4774.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/jocd.14779
Artigo de periodico
Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations (2022)
Prieto, Diego Campos ; Araujo, Renan Vinicius de ; Lima, Sara de Souza; Assad, Felipe Zauith; Grayson, Scott M; Braga, Ataualpa Albert Carmo ; Lourenço, Felipe Rebello ; Giarolla, Jeanine
Fonte: Journal of Molecular Structure. Unidades: IQ, FCF
Assuntos: TUBERCULOSE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIETO, Diego Campos et al. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, v. 1254, p. 1-7 art. 132323, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.molstruc.2021.132323. Acesso em: 08 out. 2025.
APA
Prieto, D. C., Araujo, R. V. de, Lima, S. de S., Assad, F. Z., Grayson, S. M., Braga, A. A. C., et al. (2022). Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, 1254, 1-7 art. 132323. doi:10.1016/j.molstruc.2021.132323
NLM
Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323
Vancouver
Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323
Artigo de periodico
Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs (2022)
Conceição, Juliana Rodrigues da; Lopes, Cecília Petrilli Gatti; Ferreira, Elizabeth Igne ; Epiphanio, Sabrina ; Giarolla, Jeanine
Fonte: Acta Tropica. Unidade: FCF
Assuntos: DOENÇAS NEGLIGENCIADAS, RACISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONCEIÇÃO, Juliana Rodrigues da et al. Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs. Acta Tropica, v. 235, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.actatropica.2022.106654. Acesso em: 08 out. 2025.
APA
Conceição, J. R. da, Lopes, C. P. G., Ferreira, E. I., Epiphanio, S., & Giarolla, J. (2022). Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs. Acta Tropica, 235, 1-9. doi:10.1016/j.actatropica.2022.106654
NLM
Conceição JR da, Lopes CPG, Ferreira EI, Epiphanio S, Giarolla J. Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs [Internet]. Acta Tropica. 2022 ; 235 1-9.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.actatropica.2022.106654
Vancouver
Conceição JR da, Lopes CPG, Ferreira EI, Epiphanio S, Giarolla J. Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs [Internet]. Acta Tropica. 2022 ; 235 1-9.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.actatropica.2022.106654
Artigo de periodico
Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides (2022)
Silva, João Vitor da ; Savino, Débora Feliciano; Hirata, Mario Hiroyuki ; Ferreira, Glaucio Monteiro ; Giarolla, Jeanine
Fonte: Protein and Peptide Letters. Unidade: FCF
Assuntos: ZIKA VÍRUS, PEPTÍDEOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, João Vitor da et al. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, v. 29, p. 901-910, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929866529666220919143316. Acesso em: 08 out. 2025.
APA
Silva, J. V. da, Savino, D. F., Hirata, M. H., Ferreira, G. M., & Giarolla, J. (2022). Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, 29, 901-910. doi:10.2174/0929866529666220919143316
NLM
Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/0929866529666220919143316
Vancouver
Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/0929866529666220919143316
Parte de monografia/livro
Advances in targeted dendrimers for cancer therapy and challenges for clinical translation (2021)
Silva, João Vitor da ; Santos, Soraya da Silva ; Sanches, Luccas Missfeldt ; Ferreira, Elizabeth Igne ; Giarolla, Jeanine
Fonte: Dendrimer-Based Nanotherapeutics. Unidade: FCF
Assuntos: MACROMOLÉCULA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, João Vitor da et al. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation. Dendrimer-Based Nanotherapeutics. Tradução . Waltham: Elsevier, 2021. . Disponível em: https://doi.org/10.1016/B978-0-12-821250-9.00003-2. Acesso em: 08 out. 2025.
APA
Silva, J. V. da, Santos, S. da S., Sanches, L. M., Ferreira, E. I., & Giarolla, J. (2021). Advances in targeted dendrimers for cancer therapy and challenges for clinical translation. In Dendrimer-Based Nanotherapeutics. Waltham: Elsevier. doi:10.1016/B978-0-12-821250-9.00003-2
NLM
Silva JV da, Santos S da S, Sanches LM, Ferreira EI, Giarolla J. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation [Internet]. In: Dendrimer-Based Nanotherapeutics. Waltham: Elsevier; 2021. [citado 2025 out. 08 ] Available from: https://doi.org/10.1016/B978-0-12-821250-9.00003-2
Vancouver
Silva JV da, Santos S da S, Sanches LM, Ferreira EI, Giarolla J. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation [Internet]. In: Dendrimer-Based Nanotherapeutics. Waltham: Elsevier; 2021. [citado 2025 out. 08 ] Available from: https://doi.org/10.1016/B978-0-12-821250-9.00003-2

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

País de publicação

Agência de fomento

Afiliação dos autores externos não normalizada